Genetic variant near cytosolic phospholipase A2 associated with schizophrenia
- 23 August 1996
- journal article
- Published by Elsevier in Schizophrenia Research
- Vol. 21 (2) , 111-116
- https://doi.org/10.1016/0920-9964(96)00031-x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Increased platelet phospholipase A2 activity in schizophreniaSchizophrenia Research, 1995
- A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseasesSchizophrenia Research, 1994
- Phospholipase A2 enzymes: regulation and inhibitionTrends in Pharmacological Sciences, 1993
- A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAPCell, 1991
- Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's diseaseTrends in Neurosciences, 1990
- NMDA receptors activate the arachidonic acid cascade system in striatal neuronsNature, 1988
- The current status of the dopamine hypothesis of schizophreniaNeuropsychopharmacology, 1988
- Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculationsAnnals of Human Genetics, 1987
- Increased plasma phospholipase-A2 activity in schizophrenic patients: Reduction after neuroleptic therapyBiological Psychiatry, 1987
- College student norms on the brief symptom inventoryJournal of Clinical Psychology, 1985